R&D Transforming drug development with statistical methodologies The product development lifecycle is long and challenging.
Market Access Pharmacogenomics and IVDR: Overcoming transition challenges In recent years, the in vitro diagnostics (IVD) regulatory landscape in Europe has changed and we are now in the transition from IVD Directive 98/79/EC (IVDD) to In Vitro
R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
